|
CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and …
Business Wire (press release) BUSINESS WIRE)–CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it has priced a “best efforts” underwritten public offering of common stock and warrants at a combined price of $0.76 for aggregate gross … |
